Serbia vs Türkiye: Stomach cancer death rate
Serbia
5.77 deaths per 100,000 people
in 2023
Türkiye
5.81 deaths per 100,000 people
in 2023
Serbia rank
43rd
Türkiye rank
42nd
Stomach cancer death rate over time
- Serbia
- Türkiye
How they compare
Türkiye currently reports 5.81 deaths per 100,000 people against 5.77 deaths per 100,000 people in Serbia, a difference of 0.04 deaths per 100,000 people.
The two have swapped places 1 time across 15 shared years of data; in 2009 it was Serbia ahead.
Serbia ranks 43rd and Türkiye ranks 42nd of 111 countries.
Across the 3 decades both report, Serbia averaged higher in 1 and Türkiye in 2.
Head to head by decade
| Decade | Serbia | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.61 deaths per 100,000 people | 7.91 deaths per 100,000 people | 0.6954 deaths per 100,000 people | Serbia |
| 2010s | 6.79 deaths per 100,000 people | 8.23 deaths per 100,000 people | 1.44 deaths per 100,000 people | Türkiye |
| 2020s | 5.33 deaths per 100,000 people | 6.13 deaths per 100,000 people | 0.8059 deaths per 100,000 people | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher stomach cancer death rate, Serbia or Türkiye?
- Türkiye, at 5.81 deaths per 100,000 people against 5.77 deaths per 100,000 people in Serbia as of 2023.
- What is the difference in stomach cancer death rate between Serbia and Türkiye?
- 0.04 deaths per 100,000 people, with Türkiye ahead.
- How many years of comparable data are there for Serbia and Türkiye?
- 15 years are reported by both, from 2009 to 2023.
- How do Serbia and Türkiye rank globally for stomach cancer death rate?
- Serbia ranks 43rd and Türkiye ranks 42nd of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Stomach cancer death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from stomach cancer in both sexes in those aged all ages per 100,000 people.